{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:41:04Z","timestamp":1762270864879},"publisher-location":"Boston","reference-count":14,"publisher":"Kluwer Academic Publishers","isbn-type":[{"type":"print","value":"0306477572"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/0-306-48382-3_52","type":"book-chapter","created":{"date-parts":[[2006,2,18]],"date-time":"2006-02-18T20:57:40Z","timestamp":1140296260000},"page":"261-265","source":"Crossref","is-referenced-by-count":10,"title":["Serum Levels of Soluble TNF-\u03b1 Receptor-II (P75), Circulating \u03b3\u03b4 T-Cells and Adamantiades-beh\u00e7et\u2019s Disease Activity"],"prefix":"10.1007","author":[{"given":"Antonia V.","family":"Elezoglou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter P.","family":"Sfikakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Vaiopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violeta","family":"Kapsimali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phaedon G.","family":"Kaklamanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"52_CR1","unstructured":"Yazici, H., 1994, Beh\u00e7et\u2019s syndrome. In Rheumatology (J.H. Klippel, P.A. Dieppe, eds.), Mosby-Year Book Europe."},{"key":"52_CR2","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T. Sakane","year":"1999","unstructured":"Sakane, T., Takeno, M., Suzuki, N., et al., 1999, Beh\u00e7et\u2019s disease. N. Engl. J. Med. 341: 1284\u20131291.","journal-title":"N. Engl. J. Med."},{"key":"52_CR3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1365-2249.1999.00931.x","volume":"117","author":"H. Direskeli","year":"1999","unstructured":"Direskeli, H., Eksioglu-Demiralp, E., Kibaroglu, A., et al., 1999, Oligoclonal T cell expansions in Beh\u00e7et\u2019s disease. Clin. Exp. Immunol. 117: 166\u2013170","journal-title":"Clin. Exp. Immunol."},{"key":"52_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1365-2249.1997.274-ce1159.x","volume":"107","author":"N. Yamashita","year":"1997","unstructured":"Yamashita, N., Kaneoka, H., Kaneko, S., et al., 1997, Role of \u03b3\u03b4 T lymphocytes in the development of Beh\u00e7et\u2019s disease. Clin. Exp. Immunol. 107: 241\u2013247.","journal-title":"Clin. Exp. Immunol."},{"key":"52_CR5","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.4049\/jimmunol.157.8.3672","volume":"157","author":"P.H. Hart","year":"1996","unstructured":"Hart, P.H., Hunt E.K., Bonder, C.S., et al., 1996, Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophage by IL-4 and IL-10. J. Immunol. 157: 3672\u20133680.","journal-title":"J. Immunol."},{"key":"52_CR6","first-page":"382","volume":"22","author":"A.P. Cope","year":"1995","unstructured":"Cope, A.P., and Maini, R.N., 1995, Soluble TNF receptors in arthritis. J. Rheumatol. 22: 382\u2013384.","journal-title":"J. Rheumatol."},{"key":"52_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0049-0172(96)80042-4","volume":"26","author":"A.L. Weckmann","year":"1996","unstructured":"Weckmann, A.L., and Alcocer-Verela, J., 1996, Cytokine inhibitors in autoimmune disease. Semin. Arthritis Rheum. 26: 539\u2013557.","journal-title":"Semin. Arthritis Rheum."},{"key":"52_CR8","first-page":"321","volume":"23","author":"N. Sayinalp","year":"1996","unstructured":"Sayinalp, N., Ozcebe, O.I., Ozdemir, O., et al., 1996, Cytokines in Beh\u00e7et\u2019s disease. J. Rheumatol. 23: 321\u2013322.","journal-title":"J. Rheumatol."},{"key":"52_CR9","first-page":"128","volume":"24","author":"B. Turan","year":"1997","unstructured":"Turan, B., Gallati, H., Erdi, H., et al., 1997, Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Beh\u00e7et\u2019s disease; soluble TNFR-75 as a biological marker of disease activity. J. Rheumatol. 24: 128\u2013132.","journal-title":"J. Rheumatol."},{"key":"52_CR10","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s Disease","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease, 1990, Criteria for diagnosis of Beh\u00e7et\u2019s Disease. Lancet 335: 1078\u20131080.","journal-title":"Lancet"},{"key":"52_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","volume":"358","author":"P.P. Sfikakis","year":"2001","unstructured":"Sfikakis, P.P., Theodosiades, P.G., Katsiari, C.G., et al., 2001, Effect of infliximab on sight-threatening panuveitis in Beh\u00e7et\u2019s disease. Lancet 358: 295\u2013296.","journal-title":"Lancet"},{"key":"52_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1006\/clim.2001.5172","volume":"103","author":"C.G. Katsiari","year":"2002","unstructured":"Katsiari, C.G., Liossis, S.-N.C., Souliotis, V.L., et al., 2002, Aberrant expression of the costimulatory molecule CD40L on monocytes from patients with systemic lupus erythematosus. Clin. Immunol. 103: 54\u201362.","journal-title":"Clin. Immunol."},{"key":"52_CR13","first-page":"303","volume":"24","author":"C. Gabay","year":"1997","unstructured":"Gabay, C., Cakir, N., Moral, F., et al., 1997, Circulating levels of TNF soluble receptors in SLE are significantly higher than in other rheumatic diseases and correlate with disease activity. J. Rheumatol. 24: 303\u2013308.","journal-title":"J. Rheumatol."},{"key":"52_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/BF00920240","volume":"13","author":"B. Heilig","year":"1993","unstructured":"Heilig, B., Fiehn, C., Brockhaus, M., et al., 1993, Evaluation of soluble TNF receptors in patients with SLE, PSS and MCTD. J. Clin. Immunol. 13: 321\u2013328.","journal-title":"J. Clin. Immunol."}],"container-title":["Advances in Experimental Medicine and Biology","Adamantiades-Beh\u00e7et\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/0-306-48382-3_52.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T00:48:35Z","timestamp":1706921315000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/0-306-48382-3_52"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["0306477572"],"references-count":14,"URL":"https:\/\/doi.org\/10.1007\/0-306-48382-3_52","relation":{},"subject":[]}}